GeneTex
United States (US)

EG-VEGF recombinant protein

Cat No. GTX65450

Application ELISA, Functional Assay, Apuri, Blocking
Reactivity Human
Species Human
APPLICATION

Calculated MW

9.5 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Buffer

a 0.2 μm filtered solution in PBS

Storage

Reconstitute in sterile PBS to a concentration of 0.1-1.0 mg/ml containing 0.1% BSA. This solution can then be diluted into other aqueous buffers. Stored at -20ºC for future use.

Antigen Species

Human

Expression System

Mouse myeloma cell line

Purification


Purity was assessed by SDS-PAGE (≥98%) and by HPLC (≥98%).

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Prokineticin1, PROK1, PK1, EG-VEGF, Prokineticin 1, PRK1, EGVEGF, EG VEGF

Background

Human EG-VEGF (Endocrine-gland-derived Vascular endothelial growth factor) induces proliferation, migration and fenestration in capillary endothelial cells derived from endocrine glands. Recombinant EG-VEGF has a calculated molecular mass of approximately 9.5 kDa protein consisting of 86 amino acid residues.

Research Area